Health Care Stayed Front And Center At Democratic Debate
The topic, which polls show is top of mind among voters, kept returning throughout the fourth debate of Democratic presidential candidates.
Drugs
721-740 of 1,314 results
-
-
Think 鈥楳edicare For All鈥 Is The Only Democratic Health Plan? Think Again
The Democratic presidential candidates have hit hard on health care, but generally the debates have centered on what kind of system candidates propose. The candidates鈥 ideas on many other issues, such as mental health and gun safety, have attracted much less attention.
-
California鈥檚 New Transparency Law Reveals Steep Rise In Wholesale Drug Prices
Pharmaceutical companies raised the wholesale cost of their drugs by a median of nearly 26% from 2017 to early 2019, according to California鈥檚 first-ever report stemming from a new drug price transparency law. Prices for generic drugs rose nearly 38% during that time.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
-
As Medicare Enrollment Nears, Popular Price Comparison Tool Is Missing
For more than a decade, customers used the online plan finder to compare dozens of policies. Yet after a redesign of the website, the search results no longer list which plan offers a customer the best value. Federal officials say it will be fixed before enrollment begins next week.
By Susan Jaffe -
Where Contraception鈥檚 A Lifestyle Drug Not A Medical Need 鈥 So Women Pay The Tab
Unlike in the U.S., health insurance in Germany doesn鈥檛 cover birth control. German health advocates say that causes health problems 鈥 but change is unlikely.
-
KHN鈥檚 鈥榃hat The Health?鈥: Trump Turns To Medicare
President Donald Trump, dogged by an impeachment inquiry, tries to change the subject by unveiling an executive order aimed at expanding the role of private Medicare health plans. The Trump administration also launched an effort this week to expand 鈥渨ellness鈥 programs aimed at getting people with insurance to practice better health habits 鈥 even though research has shown the efforts don鈥檛 generally improve health or save money. This week, Alice Miranda Ollstein of Politico, Kimberly Leonard of the Washington Examiner and Rebecca Adams of CQ Roll Call join KHN鈥檚 Julie Rovner to discuss these issues and more.
-
Pediatricians Stand By Meds For ADHD, But Some Say Therapy Should Come First
The American Academy of Pediatrics is out with new guidelines on ADHD that some hoped would boost the role of behavioral interventions before medications. But the AAP stuck by its recommendation that children 6 and older should be given medicine combined with therapy after diagnosis.
-
KHN鈥檚 鈥榃hat The Health?鈥: Impeachment And The Health Agenda
Washington is abuzz with impeachment talk, but what impact would such a move have on congressional action on prescription drug prices and surprise bills? Also, a study out this week shows that health insurance costs for both employers and workers continue to rise. This week, Joanne Kenen of Politico, Paige Winfield Cunningham of The Washington Post and Rebecca Adams of CQ Roll Call join KHN鈥檚 Julie Rovner to discuss these issues and more.
-
In Tiny Doses, An Addiction Medication Moonlights As Treatment For Chronic Pain
Naltrexone, commonly used for opioid and alcohol use disorders, may also help patients with chronic pain 鈥 when prescribed in low doses. But few doctors or patients seem to know about it.
-
As Off-Label Use Spreads, Supplies Of Niche Drugs And Patients鈥 Patience Grow Short
The reasons behind one particular shortage of a therapy known as IVIG are complicated, stemming from increased demand and the medication鈥檚 long production window.
-
Hill Hodgepodge: Pelosi Draws From Democrats, GOP And Trump For Drug Plan
The House speaker announced her plan for lowering drug prices, which includes negotiations between drugmakers and federal health officials.
-
KHN鈥檚 鈥榃hat The Health?鈥: Tennessee Seeks Medicaid Changes
Tennessee wants to convert its Medicaid program to a block grant. But is its plan legal? Meanwhile, Congress continues to struggle with legislation to rein in prescription drug prices and surprise medical bills. This week, Anna Edney of Bloomberg News, Jennifer Haberkorn of the Los Angeles Times and Kimberly Leonard of the Washington Examiner join KHN鈥檚 Julie Rovner to discuss these issues and more. Rovner also interviews Dr. Marty Makary, author of the new book 鈥淭he Price We Pay鈥 about why health care costs so much.
-
Longtime Crusader Against OxyContin Begins To See The Fruits Of Her Struggle
Barbara Van Rooyan lost her son to the drug 15 years ago and has fought ceaselessly since then to hold Purdue Pharma accountable for its role in the opioid crisis.
-
Purveyors Of Black-Market Pharmaceuticals Target Immigrants
Illegal medications, sold in immigrant communities around the United States, can cause serious harm to consumers, authorities say. Law enforcement officers are cracking down, but some think more must be done.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
-
KHN鈥檚 鈥榃hat The Health?鈥: Despite Booming Economy, Uninsured Rate Ticks Up
Nearly 2 million more Americans were uninsured in 2018 than in the previous year, according to the Census Bureau鈥檚 annual report. Plus, the Trump administration announced plans to ban flavored vape liquids, and Congress is back and working to address high prescription drug prices and 鈥渟urprise鈥 medical bills. This week, Joanne Kenen of Politico, Tami Luhby of CNN and Rebecca Adams of CQ Roll Call join KHN鈥檚 Julie Rovner to discuss these issues and more.
-
Congress Rakes In Millions From Drugmakers
In the first six months of this year, pharmaceutical firms and their trade groups donated almost $4 million to the campaigns of a variety of senators and House members.
-
Legislation To End Surprise Medical Bills Has High Public Support 鈥 In Both Parties
Almost 80% of Americans support efforts in Congress to protect patients from bills that come from doctors or hospitals that were outside their insurance network.
-
States Pass Record Number Of Laws To Reel In Drug Prices
So far this year, 33 states have enacted more than 50 measures to address drug prices, affordability and access. Congress is eyeing the efforts to see what works.